An institution which is designated by NCI as a comprehensive or clinical cancer center and is eligible to conduct IND drug studies
NCI Community Oncology Research Program. NCORP is a community-based program that builds upon the scope and activities of NCI’s previously supported community networks.
National Clinical Trials Network. Founded in 2014 by NCI after a report by the Institute of Medicine on the cooperative group system called for a more effective and efficient way to run trials
New Drug Application. The formal process by which the FDA makes a previously investigational drug generally available to patients and physicians for specific indications.
A group of highly-qualified clinical researchers at an institution approved by IDB to participate in NCI’s drug development program.
Noninstitutional Investigator Agreement. An OHRP-authorized document entered into between a signatory institution and a non-institutional affiliate investigator (e.g., private practitioner), which assures compliance with 45 CFR 46 for a specified activity (e.g., cooperative oncology group trials).
An adult clinical trial group sponsored by the NCI, supporting research as one of the five members of the NCTN.